The antibodies in Evusheld, the only therapy available to protect people with reduced immune function against Covid-19, may lose their punch against the BA.4.6 subvariant, a new study shows.
Source: Covid-19: New Omicron offshoot BA.4.6 evades protection of Evusheld antibodies, study finds – CNN
